drugset / Trial / NCT02802215

Metformin for Prevention Gestational Diabetes in Pregnant Women With Polycystic Ovarian Syndrome

NCT02802215

Phase 2/3 Unknown 80 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

Randomized, placebo controlled clinical trial that evaluate the role of taking metformin therapy during pregnancy in women with polycystic ovarian syndrome(PCOS) in reducing the development of gestational diabetes(GDM) and improving pregnancy outcomes.

Timeline

Start
2016-01
Primary completion
2016-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg Oral